Citation Impact
Citing Papers
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
Endogenous tissue-type plasminogen activator and risk of myocardial infarction
1993
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
2001 Standout
Postinfarction Use of β-Blockers in Elderly Patients
1997
Vascular dementia
2015 Standout
“U” curve association of blood pressure and mortality in hemodialysis patients
1998
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
1998
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Hypertension in the Very Elderly Trial (HYVET)
2001
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Prognostic implications of left ventricular hypertrophy
2001
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
1999
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
New Antithrombotic Drugs
2012
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
2000
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients
2000
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials
1999
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The Relationship between Ankle‐Arm Index and Mortality in Older Men and Women
1993
Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures
2002
Platelet Activation and Atherothrombosis
2007 Standout
Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis
2010
Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population
2003
Pharmacology of Antiplatelet Agents
2013
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Office Blood Pressure Variability as a Predictor of Brain Infarction in Elderly Hypertensive Patients.
2000
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
1992 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension
1999
Subgroup and Per-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly
1998
Cardiovascular protection and blood pressure reduction: a meta-analysis
2001
Myocarditis
2000 Standout
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
1994
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Adipose-derived adult stromal cells heal critical-size mouse calvarial defects
2004 Standout
Global burden of blood-pressure-related disease, 2001
2008 Standout
In vivo evaluation of a novel porous hydroxyapatite to sustain osteogenesis of transplanted bone marrow-derived osteoblastic cells
2001
Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure
2012
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Task Force II: Blood pressure measurement and cardiovacular outcome
2001
On-Treatment Diastolic Blood Pressure and Prognosis in Systolic Hypertension
2007
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
1998
J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data
2002
Human viral cardiomyopathy
2003
The Role of Diastolic Blood Pressure When Treating Isolated Systolic Hypertension
1999
Identification of meta-analyses
1990
Experimental Autoimmune Myocarditis Produced by Adoptive Transfer of Splenocytes After Myocardial Infarction
1998
The Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>
2002
The Prevalence of Asymptomatic and Unrecognized Peripheral Arterial Occlusive Disease
1996
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
1995 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
The J-curve phenomenon in stroke recurrence.
1993
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings.
1983
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Prognostic Value of Ambulatory Blood Pressure
2000
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
2001 Standout
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
2009
Freezing as a Path to Build Complex Composites
2006 StandoutScience
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
2004 Standout
The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk
1997
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
PLACEBO-CONTROLLED COMPARISON OF CAPTOPRIL, ATENOLOL, LABETALOL, AND PINDOLOL IN HYPERTENSION COMPLICATED BY INTERMITTENT CLAUDICATION
1987
Influence of porosity and pore size on the compressive strength of porous hydroxyapatite ceramic
1997
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Proposal of Reference Values for Home Blood Pressure Measurement Prognostic Criteria Based on a Prospective Observation of the General Population in Ohasama, Japan
1997
Influence of body and arm position on blood pressure readings
2003
Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates.
1991
Arterial Stiffness as Underlying Mechanism of Disagreement Between an Oscillometric Blood Pressure Monitor and a Sphygmomanometer
2000
Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension
2000
Fate in intermittent claudication: outcome and risk factors.
1986
Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection
2001
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Heart-specific autoantibodies induced by Coxsackievirus B3: Identification of heart autoantigens
1987
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality
2005
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Terminal digit preference and single-number preference in the Syst-Eur trial: influence of quality control
2002
Diabetes Mellitus, Hypercholesterolemia, and Hypertension but Not Vascular Disease Per Se Are Associated With Persistent Platelet Activation In Vivo
1997
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.
1991
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of D Clément being referenced
Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly.
1989
Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.
1987
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study
2010
Left Ventricular Function and Regression of Left Ventricular Hypertrophy in Essential Hypertension
1993
Plasma tissue plasminogen activator levels in patients with coronary heart disease
1988
Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress
1995
Twenty-four hour blood pressure monitoring in the Syst-Eur trial
1992
Coagulation system activation and increase of D‐dimer levels in peripheral arterial occlusive disease
1993
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization
1991
Association of anti-heart antibodies and circulating immune complexes in the post-pericardiotomy syndrome.
1984
Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication
1983
The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty.
1996
Is Blood Pressure Variability Related to Activity of the Sympathetic System?
1979
Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice
1996
Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification.
1986
Ambulatory blood pressure and prognosis: summary of ongoing studies.
1991
Influence of the arterial blood pressure and nonhemodynamic factors on regional arterial wall properties in moderate essential hypertension.
1996
Characteristic anti-heart antibody patterns in post-cardiac injury syndrome, endocarditis and acute myocarditis
1987
Relationship between age, fibrinogen level and clinical status in 313 patients with chronic venous insufficiency
1995
Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease
1981
Embolization complicating coronary angioplasty in the presence of an intracoronary thrombus
1986
Effect of Ketanserin in the Treatment of Patients with Intermittent Claudication
1987
Detection of anti-contractile antibodies after cardiac surgery using ELISA assay.
1985
Fate of the patient with chronic leg ischaemia. A review article.
1989